Cost-Effectiveness Analysis of Diagnosis of Duchenne/Becker Muscular Dystrophy in Colombia

Main|Search|PHGKB






Last Posted: Mar 15, 2018

---

• Cost-Effectiveness Analysis of Diagnosis of Duchenne/Becker Muscular Dystrophy in Colombia.  
  Atehortúa Sara C et al. Value in health regional issues 2018 Mar 171-6
• The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States.  
  Jutkowitz Eric et al. Seminars in arthritis and rheumatism 2017 Apr 46(5) 594-600
• The Role of Cost-Effectiveness Analysis in Precision Medicine and Public Health Genomics
  CDC Public Health Genomics Webinar, March 27, 2018
• Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes.  
  Dunn Paul et al. Frontiers in genetics 2018 920
• Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.  
  Schwarze Katharina et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Feb
• Economics of Pharmacogenetic-Guided Treatments: Underwhelming or Overstated?  
  Hughes Dyfrig A et al. Clinical pharmacology and therapeutics 2018 Feb

more